eflornithine + lomustine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for eflornithine + lomustine, covering 2022-01-21 to 2022-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients [Phase 3]